As of January 2025, Apex Biotechnology has a market cap of $92.01M. This makes Apex Biotechnology the world's 20170th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $103.47M | -16.00% |
2023 | $123.18M | 57.73% |
2022 | $78.10M | -1.73% |
2021 | $79.47M | 9.70% |
2020 | $72.44M | -16.40% |
2019 | $86.66M | -4.55% |
2018 | $90.78M | -6.90% |
2017 | $97.51M | -22.76% |
2016 | $126.24M | -12.13% |
2015 | $143.66M | -19.52% |
2014 | $178.51M | -14.12% |
2013 | $207.85M | -9.33% |
2012 | $229.25M | 24.56% |
2011 | $184.05M | -11.95% |
2010 | $209.04M | 7.36% |
2009 | $194.71M | 53.90% |
2008 | $126.52M | -34.14% |
2007 | $192.10M | 85.03% |
2006 | $103.82M | 79.00% |
2005 | $58.00M | 14.22% |
2004 | $50.78M | -37.86% |
2003 | $81.72M | -10.68% |
2002 | $91.49M | -28.61% |
2001 | $128.15M | 3.29% |
2000 | $124.06M | - |